logo BDSP

Base documentaire

  1. Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians : a prospective study.

    Article - En anglais

    High levels of dehydroepiandrosterone sulfate (DHEAS) have been associated with decreased risks of cardiovascular disease.

    The authors analyzed DHEAS in plasma collected at baseline among 169 participants in the Physicians'Health Study who subsequently had a myocardial infarction and 169 matched controls.

    The mean prediagnostic plasma DHEAS levels between cases (p=0.33) (mean, 3.54 mumol/liter ; standard deviation, 2.30) and controls (mean, 3.61 mumol/liter ; standard deviation, 2.16) did not differ significantly.

    The relative risk was 1.04 (95 percent confidence interval 0.42-2.60) comparing extreme quintiles after adjustment for several coronary risk factors.

    Mots-clés Pascal : Infarctus, Myocarde, Homme, Mâle, Epidémiologie, Taux, Déhydroépiandrostérone, Prévention, Prospective, Hormone stéroïde sexuelle, Androgène, Médecin, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie

    Mots-clés Pascal anglais : Infarct, Myocardium, Human, Male, Epidemiology, Rate, Dehydroepiandrosterone, Prevention, Prospective, Sex steroid hormone, Androgen, Physician, Cardiovascular disease, Coronary heart disease, Myocardial disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0074239

    Code Inist : 002B12A03. Création : 09/06/1995.